Viridian Therapeutics, Inc./DE Dividends Declared
Viridian Therapeutics, Inc./DE (VRDN) reported Dividends Declared of $285.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-27.
Discontinued › Shareholders' Equity
us-gaap:Dividends · last filed 2015-03-27
- Viridian Therapeutics, Inc./DE dividends for the quarter ending 2013-12-31 was $45.00K.
- Viridian Therapeutics, Inc./DE dividends for the quarter ending 2013-09-30 was $60.00K.
- Viridian Therapeutics, Inc./DE dividends for the quarter ending 2013-06-30 was $90.00K.
- Viridian Therapeutics, Inc./DE dividends for fiscal 2013 was $285.00K.
| Period end | Dividends 3 month | Dividends 6 month | Dividends 9 month | Dividends 12 month |
|---|---|---|---|---|
| 2013-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $105.00K derived: sum of 2 quarters · filed 2015-03-27 | $195.00K derived: sum of 3 quarters · filed 2015-03-27 | $285.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $60.00K 10-Q · filed 2014-11-14 | $150.00K derived: sum of 2 quarters · filed 2014-11-14 | $240.00K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $90.00K 10-Q · filed 2014-08-14 | $180.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |